Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Izumi

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Cureus|May 5, 2025
Dupilumab-Induced Psoriasis in a Patient With Prurigo Nodularis: A Case ReportHiroki Ogawa, Kentaro Izumi
The Journal of Dermatology|June 27, 2021
Case of bullous pemphigoid positive for full-length BP180 ELISA accompanied by immunological reconstitution due to antiretroviral therapy for human immunodeficiency virus infectionMizuki Goto, Kentaro Izumi, Yutaka Hatano
Frontiers in Immunology|May 28, 2019
Current Clinical Trials in Pemphigus and PemphigoidKentaro Izumi, Katja Bieber, Ralf J Ludwig
Frontiers in Immunology|June 14, 2019
Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180Yosuke Mai, Wataru Nishie, Kentaro Izumi, et al.
Frontiers in Immunology|August 25, 2022
The significance of preclinical anti-BP180 autoantibodiesYosuke Mai, Kentaro Izumi, Shoko Mai, et al.
The Journal of Dermatology|October 26, 2024
A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single-center retrospective observational studySho Katayama, Kentaro Izumi, Inkin Ujiie, et al.
Frontiers in Immunology|July 13, 2019
A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV InhibitorsKentaro Izumi, Wataru Nishie, Mutsuo Beniko, et al.
Zookeys|October 30, 2023
Phylogeography and genetic diversity of the Japanese mud shrimp <i>Upogebiamajor</i> (Crustacea, Decapoda, Upogebiidae): Natural or anthropogenic dispersal?Kyosuke Kitabatake, Kentaro Izumi, Natsuko I Kondo, et al.
Plos One|March 19, 2025
Sedimentary DNA is a promising indicator of the abundance of marine benthos: Insights from the burrowing decapod Upogebia majorKyosuke Kitabatake, Kentaro Izumi, Natsuko Ito-Kondo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2023
Bullous pemphigoid with autoantibodies against full-length BP180 protein after COVID-19 infectionKazumasa Oya, Masakazu Kakurai, Kentaro Izumi, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Cureus|May 5, 2025
Dupilumab-Induced Psoriasis in a Patient With Prurigo Nodularis: A Case ReportHiroki Ogawa, Kentaro Izumi
The Journal of Dermatology|June 27, 2021
Case of bullous pemphigoid positive for full-length BP180 ELISA accompanied by immunological reconstitution due to antiretroviral therapy for human immunodeficiency virus infectionMizuki Goto, Kentaro Izumi, Yutaka Hatano
Frontiers in Immunology|May 28, 2019
Current Clinical Trials in Pemphigus and PemphigoidKentaro Izumi, Katja Bieber, Ralf J Ludwig
Frontiers in Immunology|June 14, 2019
Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180Yosuke Mai, Wataru Nishie, Kentaro Izumi, et al.
Frontiers in Immunology|August 25, 2022
The significance of preclinical anti-BP180 autoantibodiesYosuke Mai, Kentaro Izumi, Shoko Mai, et al.
The Journal of Dermatology|October 26, 2024
A case of rapidly progressive hair loss due to azathioprine, and the prevalence of NUDT15 variants among Japanese patients with autoimmune blistering diseases: A single-center retrospective observational studySho Katayama, Kentaro Izumi, Inkin Ujiie, et al.
Frontiers in Immunology|July 13, 2019
A Cross-Sectional Study Comparing the Prevalence of Bullous Pemphigoid Autoantibodies in 275 Cases of Type II Diabetes Mellitus Treated With or Without Dipeptidyl Peptidase-IV InhibitorsKentaro Izumi, Wataru Nishie, Mutsuo Beniko, et al.
Zookeys|October 30, 2023
Phylogeography and genetic diversity of the Japanese mud shrimp <i>Upogebiamajor</i> (Crustacea, Decapoda, Upogebiidae): Natural or anthropogenic dispersal?Kyosuke Kitabatake, Kentaro Izumi, Natsuko I Kondo, et al.
Plos One|March 19, 2025
Sedimentary DNA is a promising indicator of the abundance of marine benthos: Insights from the burrowing decapod Upogebia majorKyosuke Kitabatake, Kentaro Izumi, Natsuko Ito-Kondo, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 20, 2023
Bullous pemphigoid with autoantibodies against full-length BP180 protein after COVID-19 infectionKazumasa Oya, Masakazu Kakurai, Kentaro Izumi, et al.
Pageof 10